Tafamidis
| CAS No. | 594839-88-0 |
|---|---|
| MDL No. | N/A |
| MF | C14H7Cl2NO3 |
| MW | 308.10 |
| InChI Key | TXEIIPDJKFWEEC-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Tafamidis is a 1,3-benzoxazole derivative in which the hydrogen at position 2 is replaced by a 3,5-dichlorophenyl group, resulting in 1,3-benzoxazole-6-carboxylic acid. It is used as its meglumine salt to treat transthyretin-related hereditary amyloidosis. It functions as a central nervous system drug and belongs to the classes of 1,3-benzoxazoles, monocarboxylic acids, and dichlorobenzenes. It is also the conjugate acid of tafamidis(1-).
| CAS No. | 594839-88-0 |
|---|---|
| Product Name | Tafamidis |
Irritant
Health HazardSignal Word:Danger
HCode:H315-H319-H335-H360-H362
PCode:P203-P260-P261-P263-P264-P264+P265-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P318-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501
